Sierra Summit Advisors »

Apellis Pharmaceuticals shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $222k 3.7k 59.86